SK281247B6 - Substituované deriváty 4-fenyltiazolov, spôsob ich prípravy a farmaceutické prípravky, ktoré ich obsahujú - Google Patents

Substituované deriváty 4-fenyltiazolov, spôsob ich prípravy a farmaceutické prípravky, ktoré ich obsahujú Download PDF

Info

Publication number
SK281247B6
SK281247B6 SK1633-95A SK163395A SK281247B6 SK 281247 B6 SK281247 B6 SK 281247B6 SK 163395 A SK163395 A SK 163395A SK 281247 B6 SK281247 B6 SK 281247B6
Authority
SK
Slovakia
Prior art keywords
formula
group
carbon atoms
substituted
alkyl
Prior art date
Application number
SK1633-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK163395A3 (en
Inventor
Alain Badorc
Marie-Francoise Bordes
Cointet Paul De
Jean-Marc Herbert
Jean-Pierre Maffrand
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of SK163395A3 publication Critical patent/SK163395A3/sk
Publication of SK281247B6 publication Critical patent/SK281247B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SK1633-95A 1994-12-28 1995-12-22 Substituované deriváty 4-fenyltiazolov, spôsob ich prípravy a farmaceutické prípravky, ktoré ich obsahujú SK281247B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9415805A FR2728901B1 (fr) 1994-12-28 1994-12-28 Derives de phenyl-4-thiazoles substitues, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
SK163395A3 SK163395A3 (en) 1996-09-04
SK281247B6 true SK281247B6 (sk) 2001-01-18

Family

ID=9470360

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1633-95A SK281247B6 (sk) 1994-12-28 1995-12-22 Substituované deriváty 4-fenyltiazolov, spôsob ich prípravy a farmaceutické prípravky, ktoré ich obsahujú

Country Status (28)

Country Link
US (1) US5607952A (de)
EP (1) EP0719775B1 (de)
JP (1) JP3027110B2 (de)
KR (1) KR960022515A (de)
CN (1) CN1048726C (de)
AR (1) AR002017A1 (de)
AT (1) ATE194616T1 (de)
AU (1) AU703490B2 (de)
BR (1) BR1100524A (de)
CA (1) CA2166165A1 (de)
CZ (1) CZ346595A3 (de)
DE (1) DE69517936T2 (de)
DK (1) DK0719775T3 (de)
ES (1) ES2148458T3 (de)
FI (1) FI956278A (de)
FR (1) FR2728901B1 (de)
GR (1) GR3034582T3 (de)
HU (1) HUT75096A (de)
IL (1) IL116560A (de)
NO (1) NO306114B1 (de)
NZ (1) NZ280720A (de)
PL (1) PL312078A1 (de)
PT (1) PT719775E (de)
RU (1) RU2124515C1 (de)
SI (1) SI0719775T1 (de)
SK (1) SK281247B6 (de)
TW (1) TW418207B (de)
ZA (1) ZA9511029B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
EP1131306A2 (de) 1998-11-18 2001-09-12 Du Pont Pharmaceuticals Company Isoxazolin fibrinogen-rezeptor-antagonisten
US6319937B1 (en) 1998-11-18 2001-11-20 Dupont Pharmaceuticals Company Isoxazoline fibrinogen receptor antagonists
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
TWI284639B (en) * 2000-01-24 2007-08-01 Shionogi & Co A compound having thrombopoietin receptor agonistic effect
US20060198836A1 (en) * 2003-07-17 2006-09-07 Smithkline Beecham Corporation Method of treating hit patients with argatroban
US7601746B2 (en) * 2003-08-12 2009-10-13 Shionogi & Co., Ltd. Compounds exhibiting thrombopoietin receptor agonism
CN101068570A (zh) * 2004-05-13 2007-11-07 贝林格尔·英格海姆国际有限公司 双嘧达莫治疗血小板抑制剂的抗药性的用途
ES2375064T3 (es) * 2004-05-17 2012-02-24 Medtronic, Inc. Sistema de determinación de heparina en el lugar de atención al paciente.
EP1907383A1 (de) * 2005-06-30 2008-04-09 Prosidion Limited Gpcr-agonisten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB542363A (en) * 1940-07-03 1942-01-06 Joseph Arthur Musgrave Woodcoc Improvements in or relating to the manufacture of graphite electrodes
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
WO1993010091A2 (en) * 1991-11-14 1993-05-27 Glaxo Group Limited Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
US5405848A (en) * 1993-12-22 1995-04-11 Ortho Pharmaceutical Corporation Substituted thiazolylaminotetrahydropyridopyrimidines derivatives useful as platelet aggregation inhibitors

Also Published As

Publication number Publication date
SK163395A3 (en) 1996-09-04
FR2728901B1 (fr) 1997-03-28
NO955320L (no) 1996-07-01
FI956278A (fi) 1996-06-29
JPH08231542A (ja) 1996-09-10
ATE194616T1 (de) 2000-07-15
IL116560A (en) 2001-03-19
JP3027110B2 (ja) 2000-03-27
CN1048726C (zh) 2000-01-26
CA2166165A1 (en) 1996-06-29
IL116560A0 (en) 1996-03-31
CZ346595A3 (en) 1996-08-14
SI0719775T1 (en) 2000-12-31
NO955320D0 (no) 1995-12-27
FR2728901A1 (fr) 1996-07-05
US5607952A (en) 1997-03-04
RU2124515C1 (ru) 1999-01-10
KR960022515A (ko) 1996-07-18
DE69517936D1 (de) 2000-08-17
TW418207B (en) 2001-01-11
ES2148458T3 (es) 2000-10-16
BR1100524A (pt) 2000-03-14
DE69517936T2 (de) 2001-04-19
ZA9511029B (en) 1997-06-30
AU4070995A (en) 1996-07-04
HU9503801D0 (en) 1996-02-28
GR3034582T3 (en) 2001-01-31
AU703490B2 (en) 1999-03-25
PL312078A1 (en) 1996-07-08
AR002017A1 (es) 1998-01-07
EP0719775A1 (de) 1996-07-03
HUT75096A (en) 1997-04-28
NO306114B1 (no) 1999-09-20
PT719775E (pt) 2000-12-29
EP0719775B1 (de) 2000-07-12
CN1133289A (zh) 1996-10-16
FI956278A0 (fi) 1995-12-27
DK0719775T3 (da) 2000-10-23
NZ280720A (en) 1997-10-24

Similar Documents

Publication Publication Date Title
EP1748985B1 (de) Cyclische amidderivate und deren herstellung und verwendung als antithrombosemittel
JP4180375B2 (ja) フェニル誘導体
JP4668614B2 (ja) ベンズイミダゾール誘導体
JPH072851A (ja) 5員複素環化合物、それらの調製方法及びこれらの化合物を含む医薬組成物
JP4624982B2 (ja) 血栓症の処置のための凝固因子Xa阻害剤としての1−N−(フェニル)−2−N−(フェニル)ピラゾリジン−1,2−ジカルボキサミド誘導体
JP2002510313A (ja) 抗血栓物質
SK281247B6 (sk) Substituované deriváty 4-fenyltiazolov, spôsob ich prípravy a farmaceutické prípravky, ktoré ich obsahujú
US20080312220A1 (en) Oxadiazole Derivatives with Crth2 Receptor Activity
HUT74103A (en) Aroyl-piperidine derivative
JP2001524481A (ja) αVβ3アンタゴニストとしての1,3,4−チアジアゾール類および1,3,4−オキサジアゾール類
JP2005535630A (ja) 2−(フェニル)−2H−ピラゾール−3−カルボン酸−N−4−(チオキソ−ヘテロサイクル)−フェニル−アミド誘導体、ならびに対応するイミノ−ヘテロサイクル誘導体、および関連する化合物の、凝固因子Xaおよび/またはVIIaの阻害剤として、血栓症の治療のための使用
KR100267883B1 (ko) 티아졸린 유도체
JP2005506970A (ja) 置換イソインドール類およびそれらの使用
US7718659B2 (en) Heteroarylacetamide inhibitors of factor Xa
PT1441726E (pt) Derivados da amida do ácido fenoxi-n-/'4-(isotiazolidino-1,1-dioxido-2-il)-fenil-velerianico e outros compostos como inibidores do factor de coagulação xa no tratamento de doenças tromboembólicas e de tumores
JPH0717942A (ja) 化合物
US7166606B2 (en) Certain 1-(D-cycloproplyglycinyl)-4-piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor Xa
CZ279559B6 (cs) Deriváty amidů kyseliny thiazolidinkarboxylové mající antialergickou aktivitu,jejich příprava a použití
JPH10130241A (ja) 新規ピリドンカルボン酸誘導体又はその塩及びこれを含有する医薬
JP3220225B2 (ja) グアニジノフェノール誘導体
JP2006527720A (ja) Alk−5受容体の阻害剤としてのチアゾール
MXPA02006904A (es) Fenilamidinas sustituidas, medicinas conteniendo estos compuestos y procedimientos para su preparacion.
KR100854584B1 (ko) 피리다지논, 피리미돈 또는 피리돈 구조를 포함하는선택적인 트롬빈 억제제